Home About us Contact
|
Home About us Contact | ||
|
|
||
Male Reproductive Health (male + reproductive_health)
Selected AbstractsAndrology: Male Reproductive Health and DysfunctionINTERNATIONAL JOURNAL OF ANDROLOGY, Issue 2 2002D. Stewart Irvine BSC MD FRCOG No abstract is available for this article. [source] Adverse trends in male reproductive health: we may have reached a crucial ,tipping point'INTERNATIONAL JOURNAL OF ANDROLOGY, Issue 2 2008A.-M. Andersson Summary Healthy men produce an enormous number of sperms, far more than necessary for conception. However, several studies suggest that semen samples where the concentration of sperms is below 40 mill/mL may be associated with longer time to pregnancy or even subfertility, and specimens where the concentration of sperms is below 15 mill/mL may carry a high risk of infertility. Historic data from the 1940s show that the bulk of young men at that time had sperm counts far above 40 mill/mL with averages higher than 100 mill/mL. However, recent surveillance studies of young men from the general populations of young men in Northern Europe show that semen quality is much poorer. In Denmark approximately 40 percent of the men have now sperm counts below 40 mill/mL. A simulation assuming that average sperm count had declined from 100 mill/mL in ,old times' to a current level close to 40 mill/mL indicated that the first decline in average sperm number of 20,40 mill/mL might not have had much effect on pregnancy rates, as the majority of men would still have had counts far above the threshold value. However, due to the assumed decline in semen quality, the sperm counts of the majority of 20 year old European men are now so low that we may be close to the crucial tipping point of 40 mill/mL spermatozoa. Consequently, we must face the possibility of more infertile couples and lower fertility rates in the future. [source] How work-place conditions, environmental toxicants and lifestyle affect male reproductive function,INTERNATIONAL JOURNAL OF ANDROLOGY, Issue 5 2002Jens Peter Bonde Summary Major temporal and geographical shifts in male reproductive function is presently an issue worldwide. The hormonal disruption hypothesis has achieved considerable attention but epidemiological evidence in support of the theory is lacking. Several occupational hazards to male reproductive function are known but exposure prevalences are hardly sufficient to play a role for reduced sperm count in the general male population. Sedentary work may be an exception. Perhaps prolonged time in the sedentary position exhausts the testicular heat regulation. But so far studies addressing implications of the heat hypothesis in the general population are few. Neither change of sexual behaviour nor reduced period of sexual continence seems to be a likely explanation. Tobacco smoking and consumption of caffeine and alcoholic beverages in adulthood have a rather marginal impact on spermatogenesis and can hardly explain major shifts or regional differences in male reproductive health. However, prenatal effects following smoking during pregnancy might play a role because we have witnessed a smoking epidemic among fertile women in some countries during the second half of the twentieth century. Moreover, if genetic factors play more than a marginal role for testicular function and sperm count, pregnancy planning resulting in reduced family size during the past 100 years could possibly explain a decline in semen quality because the most fertile part of the population reproduce less while the subfertile probably continue to get a limited number of children. [source] Male reproductive health research needs and research agenda: Asian and Pacific perspectiveINTERNATIONAL JOURNAL OF ANDROLOGY, Issue S2 2000Yi-Fei Wang Enhancing male reproductive health, and increasing men's participation in it, involves encouraging a range of positive reproductive health and social behaviour by men to help ensure women's and children's well-being. More intellectual work,including research programmes,is urgently needed to clarify the conceptual framework for male reproductive health. At the Asia and the Pacific Symposium ,Intra-regional Cooperation in Reproductive Health Research' (Shanghai, China, 12,13 October 1998) the Symposium participants identified regional research needs and recommended a regional reproductive health research agenda, which addresses six key issues related to male reproductive health: (i) male contraceptive technology; (ii) reproductive tract infections/sexually transmitted diseases and male infertility; (iii) male involvement in reproductive health; (iv) male adolescent reproductive health; (v) male reproductive ageing; and (vi) environment and male reproductive health. One of the major challenges now facing us is the elaboration of a comprehensive, yet realistic, male reproductive health research agenda that reflects the needs and demands of Asian developing countries. Making full use of an interdisciplinary approach is of strategic importance to achieve this. [source] Simultaneous exposure to low concentrations of dichlorodiphenyltrichloroethane, deltamethrin, nonylphenol and phytoestrogens has negative effects on the reproductive parameters in male Spraque-Dawley ratsANDROLOGIA, Issue 4 2007E. Kilian Summary Many reports suggest that male reproductive health has deteriorated over the last decades, possibly due to environmental contaminants that act as endocrine disruptors. This hypothesis was tested in Sprague-Dawley rats using a modified Organization for Economic Cooperation and Development 415 one-generation test. Group A received cottonseed oil as control, and Groups B, C and D received deltamethrin (DM); DM and dichlorodiphenyltrichloroethane (DDT); and DM, DDT, phytoestrogens and p -nonylphenol, respectively. Rats were exposed in utero and then received the substances for 10 weeks. The seminal vesicle mass (Group B; P = 0.046) and sperm count [Groups C (P = 0.013) and D (P = 0.003)] were lower and the anogenital distance [Group B (P = 0.047) C (P = 0.045) and D (P = 0.002)] shorter compared with the control group. The seminiferous tubule diameter [Groups B (P = <0.001), C (P = <0.001) and D (P = <0.001)] and epithelium thickness [Groups B (P = 0.030), C (P = <0.001) and D (P = <0.001)] were smaller compared with the control. The histology of the testes showed signs of apical sloughing and vacuolisation. Liver weights [Groups C (P = 0.013) and D (P = 0.005)] and liver enzymes [Group D (P = 0.013)] were also affected. These findings may indicate that simultaneous exposure to endocrine disrupting compounds contributes to the deterioration observed in male reproductive health. [source] Role of valproate across the ages.ACTA NEUROLOGICA SCANDINAVICA, Issue 2006Treatment of epilepsy in adults A workshop was held in Göteborg in June 2005 to discuss the place of valproate in treating adult epilepsies. Consensus positions were developed on the epilepsy types for which the drug is most suitable and the use of valproate in women of child-bearing age, in men and in patients with psychiatric comorbidity. Valproate was considered to be effective across a broad variety of epilepsy syndromes and seizure types and should be considered a suitable choice for first-line monotherapy of juvenile myoclonic epilepsy and other idiopathic generalized epilepsies. The use of valproate by women of child-bearing age is associated with potential harm to the foetus. A conservative approach to treatment is recommended in these patients whereby alternative antiepileptic drugs should be proposed to women planning pregnancies wherever satisfactory seizure control can be thereby maintained. In cases where valproate is used during pregnancy, either because the pregnancy was unplanned or because alternative treatment options of equivalent efficacy are unavailable, appropriate counselling, precautionary measures and monitoring should be provided. The evidence for an impact of valproate on male reproductive health is equivocal and considerations of male fertility should not be taken into account in deciding whether to prescribe valproate to men. Valproate can be proposed safely to patients with comorbid psychiatric disease or underlying psychiatric vulnerability. [source] | ||||||||||